| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $56.3M | — |
| Cost of Revenue | $17.0M | — |
| Gross Profit | $39.2M | — |
| R&D Expense | $22.8M | — |
| SG&A Expense | $3.1M | — |
| Operating Income | $12.4M | — |
| Pre-tax Income | $12.6M | — |
| Income Tax | -$125K | — |
| Net Income | $12.8M | — |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.5M | — |
| Accounts Receivable | $10.7M | — |
| Inventory | $302K | — |
| Current Assets | $20.7M | — |
| Total Assets | $27.8M | — |
| Current Liabilities | $9.9M | — |
| Total Liabilities | $10.2M | — |
| Stockholders' Equity |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $16.2M | — |
| Capital Expenditures | $21K | — |
| Investing Cash Flow | -$13.2M | — |
| Financing Cash Flow | -$204K | -506.2% |
| Free Cash Flow | $16.1M | — |
| $17.6M |
| — |